{"id":"https://openalex.org/W1990460918","doi":"https://doi.org/10.1158/1535-7163.targ-11-b110","title":"Abstract B110: Early radiographic and physiologic changes in patients with recurrent low-grade gliomas treated with everolimus under a phase II clinical trial.","display_name":"Abstract B110: Early radiographic and physiologic changes in patients with recurrent low-grade gliomas treated with everolimus under a phase II clinical trial.","publication_year":2011,"publication_date":"2011-11-01","ids":{"openalex":"https://openalex.org/W1990460918","doi":"https://doi.org/10.1158/1535-7163.targ-11-b110","mag":"1990460918"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-11-b110","doi":"https://doi.org/10.1158/1535-7163.targ-11-b110","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-11-b110","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056118833","display_name":"Michael Traut Wahl","orcid":"https://orcid.org/0000-0002-5504-7354","observed_orcids":["https://orcid.org/0000-0002-5504-7354"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Wahl","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038796731","display_name":"Christopher Kazu Williams","orcid":"https://orcid.org/0000-0003-3253-7630","observed_orcids":["https://orcid.org/0000-0003-3253-7630"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Kazu Williams","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011690840","display_name":"Janine Lupo","orcid":"https://orcid.org/0000-0002-0051-6387","observed_orcids":["https://orcid.org/0000-0002-0051-6387"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janine M. Lupo","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085032736","display_name":"Daphne Adele Haas-Kogan","orcid":"https://orcid.org/0000-0002-2378-4800","observed_orcids":["https://orcid.org/0000-0002-2378-4800"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daphne Haas-Kogan","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051168746","display_name":"Sarah J. Nelson","orcid":"https://orcid.org/0000-0001-8015-5157","observed_orcids":["https://orcid.org/0000-0001-8015-5157"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah J. Nelson","raw_affiliation_strings":["1University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"11_Supplement","first_page":"B110","last_page":"B110"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12049","display_name":"Tuberous Sclerosis Complex Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.8460000157356262},{"id":"https://openalex.org/keywords/pi3k-mtor-pathway","display_name":"PI3K/mTOR pathway","score":0.9890000224113464},{"id":"https://openalex.org/keywords/fractional-blood-volume","display_name":"fractional blood volume","score":0.8460000157356262},{"id":"https://openalex.org/keywords/vascular-permeability","display_name":"vascular permeability","score":0.7419999837875366},{"id":"https://openalex.org/keywords/perfusion-mri","display_name":"perfusion MRI","score":0.6809999942779541},{"id":"https://openalex.org/keywords/apparent-diffusion-coefficient","display_name":"apparent diffusion coefficient","score":0.7450000047683716},{"id":"https://openalex.org/keywords/fractional-anisotropy","display_name":"fractional anisotropy","score":0.9829999804496765},{"id":"https://openalex.org/keywords/magnetic-resonance-spectroscopic-imaging","display_name":"magnetic resonance spectroscopic imaging","score":0.8320000171661377},{"id":"https://openalex.org/keywords/t2-hyperintensity","display_name":"T2 hyperintensity","score":0.7409999966621399},{"id":"https://openalex.org/keywords/contrast-enhancing-lesions","display_name":"contrast-enhancing lesions","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8621320724487305},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.692517101764679},{"id":"https://openalex.org/C89916169","wikidata":"https://www.wikidata.org/wiki/Q17014600","display_name":"Fractional anisotropy","level":4,"score":0.6268039345741272},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.6197803020477295},{"id":"https://openalex.org/C2781192897","wikidata":"https://www.wikidata.org/wiki/Q822050","display_name":"White matter","level":3,"score":0.4786747097969055},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.460789293050766},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4223952889442444},{"id":"https://openalex.org/C149550507","wikidata":"https://www.wikidata.org/wiki/Q899360","display_name":"Diffusion MRI","level":3,"score":0.419899046421051},{"id":"https://openalex.org/C146638467","wikidata":"https://www.wikidata.org/wiki/Q10529587","display_name":"Hyperintensity","level":3,"score":0.4100727438926697},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.40456444025039673},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.36227908730506897},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3259243965148926}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-11-b110","doi":"https://doi.org/10.1158/1535-7163.targ-11-b110","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-11-b110","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2085163752","https://openalex.org/W2557702623","https://openalex.org/W2033899400","https://openalex.org/W1972318684","https://openalex.org/W2741684011","https://openalex.org/W3015005157","https://openalex.org/W3111459713","https://openalex.org/W2983887918","https://openalex.org/W3115372780","https://openalex.org/W2320152522"],"abstract_inverted_index":{"Abstract":[0],"Low-grade":[1],"gliomas":[2,72],"(LGG)":[3],"are":[4,53,403],"slow-growing,":[5],"primary":[6,13],"brain":[7],"tumors":[8],"that":[9,32,390],"frequently":[10],"recur":[11],"after":[12,262],"surgical":[14],"treatment.":[15,96,343],"Recent":[16],"work":[17],"has":[18],"established":[19],"the":[20,23,30,101,110,129,141,170,189,200,206,234,245,265,274,281,300,308,338,360,415,435],"activation":[21],"of":[22,47,103,123,164,208,233,247,284,290,312,342,346,386,418,434],"PI3K/mTOR":[24],"pathway":[25],"in":[26,184,271,280,307,351,375,414,423],"most":[27],"LGG,":[28],"raising":[29],"possibility":[31],"mTOR":[33],"inhibitors":[34],"such":[35],"as":[36],"everolimus":[37],"(RAD001)":[38],"may":[39,364,382,412],"benefit":[40],"patients":[41,57,68,93,211,399],"with":[42,69,75,277,369],"LGG.":[43],"Early":[44],"imaging":[45,81,107,115,124,159,242,396],"markers":[46,385],"treatment":[48,248,370,389,419],"response":[49,387,420],"and":[50,109,134,146,156,167,169,188,193,202,229,253,259,289,296,304,318,327,363,400,409,441],"disease":[51,214,224],"progression":[52,215,422],"needed":[54,404],"to":[55,89,172,180,218,237,354,388,405],"assess":[56],"undergoing":[58,95],"experimental":[59],"therapy.":[60],"In":[61],"this":[62],"phase":[63],"II":[64],"clinical":[65],"trial,":[66],"17":[67],"recurrent":[70],"low-grade":[71],"were":[73,94,119,126,197,378],"treated":[74],"everolimus.":[76],"Serial":[77],"multimodal":[78],"magnetic":[79],"resonance":[80],"was":[82,178,249],"obtained":[83],"every":[84],"two":[85,230],"months":[86,91,258,261,288,294,316,322,341],"for":[87,251,334],"up":[88],"12":[90],"while":[92],"At":[97,205],"each":[98],"time":[99,207],"point,":[100],"volume":[102,144,350,377],"hyperintensity":[104],"on":[105,113],"T2-weighted":[106],"(T2ALL)":[108],"contrast-enhancing":[111],"lesion":[112],"T1-weighted":[114],"(CEL),":[116],"if":[117],"present,":[118],"manually":[120],"defined.":[121],"Maps":[122],"parameters":[125,161,329],"generated,":[127],"including":[128],"apparent":[130],"diffusion":[131,326,408],"coefficient":[132],"(ADC)":[133],"fractional":[135,142,348],"anisotropy":[136],"(FA)":[137],"from":[138,150],"diffusion-weighted":[139],"imaging,":[140,155],"blood":[143,349],"(fBV)":[145],"vascular":[147],"permeability":[148],"(Kps)":[149],"dynamic":[151],"contrast":[152],"enhanced":[153],"perfusion-weighted":[154],"MR":[157],"spectroscopic":[158,410],"derived":[160],"(peak":[162],"heights":[163],"choline,":[165],"lipid":[166],"lactate,":[168],"choline":[171],"N-acetylaspartate":[173],"index,":[174],"CNI).":[175],"Each":[176],"parameter":[177],"normalized":[179],"its":[181],"median":[182,282],"value":[183],"normal-appearing":[185],"white":[186],"matter,":[187],"median,":[190],"10th":[191],"percentile":[192,195,310],"90th":[194,309],"values":[196],"computed":[198],"within":[199,273,359],"T2ALL":[201,275],"CEL":[203],"volumes.":[204],"analysis,":[209],"four":[210],"had":[212,222],"experienced":[213],"(range":[216],"3.2":[217],"15.8":[219],"months),":[220],"11":[221],"stable":[223],"(median":[225],"follow-up":[226,402],"13.6":[227],"months)":[228],"dropped":[231],"out":[232],"study":[235],"due":[236],"adverse":[238],"side":[239],"effects.":[240],"Baseline":[241],"characteristics":[243],"at":[244,256,286,292,314,320],"beginning":[246],"similar":[250],"progressors":[252],"non-progressors.":[254],"However,":[255],"3\u20134":[257,287,315],"5\u20136":[260,293,321],"starting":[263],"treatment,":[264],"non-progressors":[266,352],"demonstrated":[267],"a":[268,278,305,355],"significant":[269],"decrease":[270,279,306],"FBV":[272,283,311],"volume,":[276,362],"31%":[285],"39%":[291],"(p=0.001":[295],"p=0.012,":[297],"respectively,":[298],"by":[299,394],"Wilcoxon":[301],"signed-rank":[302],"test)":[303],"32%":[313],"(p=0.002)":[317],"42%":[319],"(p=0.008).":[323],"Other":[324],"spectroscopic,":[325],"perfusion":[328],"did":[330],"not":[331],"change":[332],"significantly":[333],"these":[335,380,424],"subjects":[336],"during":[337],"first":[339],"6":[340],"The":[344],"finding":[345],"reduced":[347],"corresponds":[353],"decreased":[356,366],"capillary":[357],"density":[358],"tumor":[361,376],"represent":[365,383],"angiogenesis":[367],"associated":[368],"effect.":[371],"Since":[372],"no":[373],"changes":[374],"observed,":[379],"findings":[381],"early":[384,416],"cannot":[391],"be":[392],"assessed":[393],"anatomic":[395],"alone.":[397],"More":[398],"longer":[401],"determine":[406],"whether":[407],"data":[411],"aid":[413],"detection":[417],"or":[421],"patients.":[425],"Citation":[426],"Format:":[427],"{Authors}.":[428],"{Abstract":[429],"title}":[430],"[abstract].":[431],"In:":[432],"Proceedings":[433],"AACR-NCI-EORTC":[436],"International":[437],"Conference:":[438],"Molecular":[439],"Targets":[440],"Cancer":[442,454],"Therapeutics;":[443],"2011":[444],"Nov":[445],"12-16;":[446],"San":[447],"Francisco,":[448],"CA.":[449],"Philadelphia":[450],"(PA):":[451],"AACR;":[452],"Mol":[453],"Ther":[455],"2011;10(11":[456],"Suppl):Abstract":[457],"nr":[458],"B110.":[459]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}